drugset / Trial / NCT00446485
Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine weather Ginkgo biloba standardized extract (24% ginkoflavonoglicozides and 6% terpenes) is effective in treatment of cognitive and concentration impairment
Timeline
- Start
- 2007-05
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ginkgo biloba standardized extract 24/6 | Unknown | 60 mg | — |
| Comparator | Ginkgo biloba standardized extract 24/6 | Unknown | 120 mg | — |